how long have glp-1 drugs been on the market Chart: 1 in 8 Americans Now Use for Weight Loss GLP-1 Receptor Agonists Obesity Drugs
Description
M., Birkenfeld, A
body weights and body composition were assessed throughout the study (Fig
10.1016/S0140-6736(14)61468-9 [DOI] [PubMed] [Google Scholar] 132.Kim M, Platt MJ, Shibasaki T, Quaggin SE, Backx PH, Seino S, et al
95% CI [0.681.13])
Manufacturers seeking to win in this space should consider how to address the following success factors: Determine whether to go broad or target a niche: Determine whether to go broad or target a niche: Going broad has been an effective strategy to date, but this may change as the market fractures
